These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25874259)

  • 1. Theragnostic imaging using radiolabeled antibodies and tyrosine kinase inhibitors.
    Yoshimoto M; Kurihara H; Fujii H
    ScientificWorldJournal; 2015; 2015():842101. PubMed ID: 25874259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET imaging with small-molecule tyrosine kinase inhibitors: TKI-PET.
    Slobbe P; Poot AJ; Windhorst AD; van Dongen GA
    Drug Discov Today; 2012 Nov; 17(21-22):1175-87. PubMed ID: 22766374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Targeting Using Radiolabeled Antibodies for Image-Guided Drug Delivery.
    Rijpkema M; Boerman OC; Oyen WJ
    Curr Drug Targets; 2015; 16(6):625-33. PubMed ID: 25355181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview.
    Chakravarty R; Goel S; Dash A; Cai W
    Q J Nucl Med Mol Imaging; 2017 Jun; 61(2):181-204. PubMed ID: 28124549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging EGFR and HER2 by PET and SPECT: a review.
    Corcoran EB; Hanson RN
    Med Res Rev; 2014 May; 34(3):596-643. PubMed ID: 24037872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging.
    Bernard-Gauthier V; Bailey JJ; Berke S; Schirrmacher R
    Molecules; 2015 Dec; 20(12):22000-27. PubMed ID: 26690113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ⁹⁹mTc-HYNIC-MPG: a novel SPECT probe for targeting mutated EGFR.
    Yan Y; Xiao ZY; Song Y; Kang ZT; Wang P; Sun XL; Shen BZ
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1647-52. PubMed ID: 25716904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis?
    Pant K; Sedláček O; Nadar RA; Hrubý M; Stephan H
    Adv Healthc Mater; 2017 Mar; 6(6):. PubMed ID: 28218487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapies.
    Widmer N; Bardin C; Chatelut E; Paci A; Beijnen J; Levêque D; Veal G; Astier A
    Eur J Cancer; 2014 Aug; 50(12):2020-36. PubMed ID: 24928190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular image-guided theranostic and personalized medicine 2014.
    Zhang H; Tian M; Carrio I; Civelek AC; Fujibayashi Y
    Biomed Res Int; 2015; 2015():258612. PubMed ID: 25883947
    [No Abstract]   [Full Text] [Related]  

  • 12. PET imaging for tyrosine kinase inhibitor (TKI) biodistribution in mice.
    Fushiki H; Murakami Y; Miyoshi S; Nishimura S
    Methods Mol Biol; 2015; 1219():199-206. PubMed ID: 25308271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls.
    Tolmachev V; Stone-Elander S; Orlova A
    Lancet Oncol; 2010 Oct; 11(10):992-1000. PubMed ID: 20667780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics.
    Cui L; Lin Q; Jin CS; Jiang W; Huang H; Ding L; Muhanna N; Irish JC; Wang F; Chen J; Zheng G
    ACS Nano; 2015; 9(4):4484-95. PubMed ID: 25830219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationally designed aberrant kinase-targeted endogenous protein nanomedicine against oncogene mutated/amplified refractory chronic myeloid leukemia.
    Retnakumari AP; Hanumanthu PL; Malarvizhi GL; Prabhu R; Sidharthan N; Thampi MV; Menon D; Mony U; Menon K; Keechilat P; Nair S; Koyakutty M
    Mol Pharm; 2012 Nov; 9(11):3062-78. PubMed ID: 22971013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tyrosine kinase inhibitor-based high-affinity PET radiopharmaceutical targets vascular endothelial growth factor receptor.
    Li F; Jiang S; Zu Y; Lee DY; Li Z
    J Nucl Med; 2014 Sep; 55(9):1525-31. PubMed ID: 24970912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule EGFR tyrosine kinase inhibitors for the treatment of cancer.
    Lee CC; Shiao HY; Wang WC; Hsieh HP
    Expert Opin Investig Drugs; 2014 Oct; 23(10):1333-48. PubMed ID: 24921970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of in vivo imaging system targeting a molecular marker].
    Furukawa T
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1269-71. PubMed ID: 18701835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theranostic Probes for Cancer Imaging.
    Wang F; Zhu L; Yang K; Park D
    Contrast Media Mol Imaging; 2017; 2017():1863803. PubMed ID: 29114172
    [No Abstract]   [Full Text] [Related]  

  • 20. Epidermal growth factor receptor: pathway, therapies, and pipeline.
    Goffin JR; Zbuk K
    Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.